Association of the Haze and Diabetes in China

Author:

Sun Jun1,Ji Jie2,Wang Yurong3,Gu Harvest F.3

Affiliation:

1. Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, 210009 Nanjing, China

2. Institute of Environment, Karolinska Institutet, 17177 Stockholm, Sweden

3. Center for Pathophysiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 210009 Nanjing, China

Abstract

Background: China, as the largest developing country in the world, has experienced rapid economic development during the past decades. As a side effect of the rapid growth of Chinese economy, air pollution in the form of haze is harmful to human health. Introduction: China is also one of the countries with the highest prevalence of diabetes in Asia and has the largest burden of diabetes in the world. Recent evidence suggests a positive correlation between air pollution and the increased risk of diabetes. However, the association of haze with diabetes is still unclear. Methods: Based upon literature searching with PubMed, the information on haze and prevalence of diabetes in different cities or provinces of China is summarized. The possible association of haze with diabetes and the perspectives of haze research particularly in the prevention of haze in China are then discussed. Results: The exposure of long-term air pollution such as haze reduces insulin-dependent glucose uptake, leading to insulin resistance; damages beta cell function, leading to decreased insulin secretion, and promotes subcutaneous fat accumulation. Pathophysiological effects of particulate matters in diabetes through inflammation and oxidative stress were evidenced by several epidemiological and experimental studies. Conclusion: A better understanding of the incidence of diabetes caused by haze exposure may facilitate policy development in air pollution prevention and intervention design in diabetes prevention. Continuous improvement in air quality may help to reduce diabetes prevalence in China.

Funder

China Pharmaceutical University

Publisher

Bentham Science Publishers Ltd.

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3